DCAPI1267 |
Dipyridamole (Persantine) |
Dipyridamole (Persantine) |
|
DCAPI1398 |
Disulfiram (Antabuse)
Featured
|
Disulfiram (Antabuse) |
|
DCAPI1335 |
Divalproex sodium |
Divalproex sodium |
|
DCAPI1183 |
DL-Carnitine HCl |
DL-Carnitine HCl |
|
DCAPI1299 |
Docosanol (Abreva) |
Docosanol (Abreva) |
|
DCAPI1022 |
Dofetilide (Tikosyn)
Featured
|
Dofetilide (Tikosyn) |
|
DC9133 |
Domperidone |
Domperidone is a dopamine blocker and an antidopaminergic reagent. |
|
DC9102 |
Donepezil |
Donepezil(E 2020) is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM, respectively. |
|
DCAPI1164 |
Doripenem Hydrate |
Doripenem Hydrate |
|
DC9061 |
Doxepin HCl |
Doxepin HCl is a tricyclic antidepressant that is marketed worldwide. |
|
DCAPI1241 |
Doxercalciferol (Hectorol)
Featured
|
Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease. |
|
DC8994 |
Doxifluridine/5-Fluoro-5′-deoxyuridine |
Doxifluridine(Ro 21-9738; 5'-DFUR) is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM. |
|
DC9109 |
Doxylamine succinate |
Doxylamine is a first generation antihistamine; can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief. |
|
DCAPI1457 |
Dronedarone Hydrochloride |
Dronedarone is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium and sodium and is a calcium channel protein inhibitor. |
|
DCAPI1441 |
Seocalcitol |
EB1089 is an analog of 1,25 dihydroxyvitamin D which acts as a vitamin D receptor (VDR). EB1089 is noted to reverse hypercalcemia and is a potent inhibitor of PTH-rP (parathyroid hormone-related peptide, PTHRP) in vitro. In studies utilizing a squamous ca |
|
DCAPI1162 |
Ecdysone |
Ecdysone |
|
DCAPI1408 |
Echinocandin B0 |
Echinocandin B0 |
|
DCAPI1126 |
Econazole nitrate (Spectazole) |
Econazole nitrate (Spectazole) |
|
DCAPI1380 |
Edaravone (MCI-186) |
Edaravone (MCI-186) |
|
DCAPI1479 |
Efavirenz |
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip |
|
DCAPI1410 |
Eldecalcitol
Featured
|
Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is an analog of 1,25-dihydroxyvitamin D3 that improves bone mineral density. Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is more efficaci |
|
DCAPI1504 |
Elocalcitol |
Elocalcitol |
|
DCAPI1196 |
Eltrombopag (SB-497115-GR)
Featured
|
Eltrombopag (SB-497115-GR) |
|
DCAPI1334 |
Enalapril maleate (Vasotec) |
Enalapril maleate (Vasotec) |
|
DCAPI1356 |
Epalrestat
Featured
|
Epalrestat is an orally active aldose reductase inhibitor that acts on diabetic neuropathy. |
|
DCAPI1014 |
Eplerenone
Featured
|
Eplerenone, also known as Inspra and CGP-30083, is a selective aldosterone receptor antagonist used to treat hypertension and congestive heart failure. Eplerenone provides marked protection against vascular injury in the kidney and heart.
|
|
DC9171 |
Eprosartan mesylate |
Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively. |
|
DCAPI1365 |
Erdosteine |
Erdosteine |
|
DCAPI1539 |
Eribulin Mesylate
Featured
|
Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma. |
|
DCAPI1516 |
Eribulin |
Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules. |
|